Brent M. Egan

Title
InstitutionMedical University of South Carolina
DepartmentGeneral Internal Medicine
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Egan BM, Sutherland SE. Editorial commentary on 'Country of birth and mortality risk in hypertension with and without diabetes: the Swedish Primary Care Cardiovascular Database'. J Hypertens. 2021 Jun 01; 39(6):1104-1106. PMID: 33967213.
      Citations:    
    2. Motta E Motta J, Souza LN, Vieira BB, Delle H, Consolim-Colombo FM, Egan BM, Lopes HF. Acute physical and mental stress resulted in an increase in fatty acids, norepinephrine, and hemodynamic changes in normal individuals: A possible pathophysiological mechanism for hypertension-Pilot study. J Clin Hypertens (Greenwich). 2021 Apr; 23(4):888-894. PMID: 33512748.
      Citations:    
    3. Egan BM, Li J, Sutherland SE, Jones DW, Ferdinand KC, Hong Y, Sanchez E. Sociodemographic Determinants of Life's Simple 7: Implications for Achieving Cardiovascular Health and Health Equity Goals. Ethn Dis. 2020; 30(4):637-650. PMID: 32989364.
      Citations:    
    4. Egan BM, Sutherland SE. Antihypertensive Treatment in Elderly Frail Patients: Evidence From a Large Italian Database. Hypertension. 2020 08; 76(2):330-332. PMID: 32639893.
      Citations:    
    5. Egan BM. Hypertension in military veterans is associated with combat exposure and combat injury. J Hypertens. 2020 07; 38(7):1255-1256. PMID: 32502093.
      Citations:    
    6. Carpenter MJ, Wahlquist AE, Dahne J, Gray KM, Garrett-Mayer E, Cummings KM, Davis R, Egan BM. Nicotine replacement therapy sampling for smoking cessation within primary care: results from a pragmatic cluster randomized clinical trial. Addiction. 2020 07; 115(7):1358-1367. PMID: 31916303.
      Citations:    
    7. Lynch OE, Aherne T, Gibbons J, Boland MR, Ryan ÉJ, Boyle E, Egan B, Tierney S. Five-year follow-up of patients treated with intra-dermal botulinum toxin for axillary hyperhidrosis. Ir J Med Sci. 2020 Aug; 189(3):1023-1026. PMID: 31898163.
      Citations:    
    8. Murphy SJX, Lim ST, Kinsella JA, Tierney S, Egan B, Feeley TM, Murphy SM, Walsh RA, Collins DR, Coughlan T, O'Neill D, Harbison JA, Madhavan P, O'Neill SM, Colgan MP, Cox D, Moran N, Hamilton G, Meaney JF, McCabe DJH. Relationship between 'on-treatment platelet reactivity', shear stress, and micro-embolic signals in asymptomatic and symptomatic carotid stenosis. J Neurol. 2020 Jan; 267(1):168-184. PMID: 31606758.
      Citations:    
    9. Egan BM. The prevalence of concurrently raised blood glucose and blood pressure in India. J Hypertens. 2019 09; 37(9):1788-1789. PMID: 31365452.
      Citations:    
    10. Egan BM. Optimal Systolic Blood Pressure Target in Resistant Hypertension. Am J Med. 2019 07; 132(7):e623. PMID: 31400795.
      Citations:    
    11. Egan BM, Sutherland SE, Tilkemeier PL, Davis RA, Rutledge V, Sinopoli A. A cluster-based approach for integrating clinical management of Medicare beneficiaries with multiple chronic conditions. PLoS One. 2019; 14(6):e0217696. PMID: 31216301.
      Citations:    
    12. Egan BM, Kjeldsen SE, Grassi G, Esler M, Mancia G. The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard? J Hypertens. 2019 06; 37(6):1148-1153. PMID: 30624370.
      Citations:    
    13. Burnier M, Egan BM. Adherence in Hypertension. Circ Res. 2019 03 29; 124(7):1124-1140. PMID: 30920917.
      Citations:    
    14. Egan BM. Implementation of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline. Hypertension. 2019 02; 73(2):288-290. PMID: 30624995.
      Citations:    
    15. Egan BM. Prognostic value of blood pressure control delay in newly diagnosed hypertensive patients. J Hypertens. 2019 02; 37(2):290-291. PMID: 30640872.
      Citations:    
    16. Dominguez RF, da Costa-Hong VA, Ferretti L, Fernandes F, Bortolotto LA, Consolim-Colombo FM, Egan BM, Lopes HF. Hypertensive heart disease: Benefit of carvedilol in hemodynamic, left ventricular remodeling, and survival. SAGE Open Med. 2019; 7:2050312118823582. PMID: 30671246.
      Citations:    
    17. Egan BM, Sutherland SE, Rakotz M, Yang J, Hanlin RB, Davis RA, Wozniak G. Improving Hypertension Control in Primary Care With the Measure Accurately, Act Rapidly, and Partner With Patients Protocol. Hypertension. 2018 12; 72(6):1320-1327. PMID: 30571231.
      Citations:    
    18. Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, Egan BM, Flack JM, Gidding SS, Judd E, Lackland DT, Laffer CL, Newton-Cheh C, Smith SM, Taler SJ, Textor SC, Turan TN, White WB. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. Hypertension. 2018 11; 72(5):e53-e90. PMID: 30354828.
      Citations:    
    19. Egan BM, Rudisill C. Cost-Utility of an Objective Biochemical Measure to Improve Adherence to Antihypertensive Treatment. Hypertension. 2018 11; 72(5):1090-1092. PMID: 30354834.
      Citations:    
    20. Egan B, Flack J, Patel M, Lombera S. Insights on ß-blockers for the treatment of hypertension: A survey of health care practitioners. J Clin Hypertens (Greenwich). 2018 10; 20(10):1464-1472. PMID: 30289609.
      Citations:    
    21. Basile J, Egan B, Punzi H, Ali S, Li Q, Patel M, Neutel J. Risk of Hospitalization for Cardiovascular Events with ß-Blockers in Hypertensive Patients: A Retrospective Cohort Study. Cardiol Ther. 2018 Dec; 7(2):173-183. PMID: 30191469.
      Citations:    
    22. Dahne J, Wahlquist AE, Boatright AS, Garrett-Mayer E, Fleming DO, Davis R, Egan B, Carpenter MJ. Nicotine replacement therapy sampling via primary care: Methods from a pragmatic cluster randomized clinical trial. Contemp Clin Trials. 2018 09; 72:1-7. PMID: 30010086.
      Citations:    
    23. Egan BM. Defining Hypertension by Blood Pressure 130/80 mm Hg Leads to an Impressive Burden of Hypertension in Young and Middle-Aged Black Adults: Follow-Up in the CARDIA Study. J Am Heart Assoc. 2018 07 14; 7(14). PMID: 30007937.
      Citations:    
    24. Egan BM, Li J, Davis RA, Fiscella KA, Tobin JN, Jones DW, Sinopoli A. Differences in primary cardiovascular disease prevention between the 2013 and 2016 cholesterol guidelines and impact of the 2017 hypertension guideline in the United States. J Clin Hypertens (Greenwich). 2018 06; 20(6):991-1000. PMID: 29774988.
      Citations:    
    25. Hanlin RB, Asif IM, Wozniak G, Sutherland SE, Shah B, Yang J, Davis RA, Bryan ST, Rakotz M, Egan BM. Measure Accurately, Act Rapidly, and Partner With Patients (MAP) improves hypertension control in medically underserved patients: Care Coordination Institute and American Medical Association Hypertension Control Project Pilot Study results. J Clin Hypertens (Greenwich). 2018 01; 20(1):79-87. PMID: 29316149.
      Citations:    
    26. Moran C, Scotto di Palumbo A, Bramham J, Moran A, Rooney B, De Vito G, Egan B. Effects of a Six-Month Multi-Ingredient Nutrition Supplement Intervention of Omega-3 Polyunsaturated Fatty Acids, vitamin D, Resveratrol, and Whey Protein on Cognitive Function in Older Adults: A Randomised, Double-Blind, Controlled Trial. J Prev Alzheimers Dis. 2018; 5(3):175-183. PMID: 29972210.
      Citations:    
    27. Egan BM, Li J, Sarasua SM, Davis RA, Fiscella KA, Tobin JN, Jones DW, Sinopoli A. Cholesterol Control Among Uninsured Adults Did Not Improve From 2001-2004 to 2009-2012 as Disparities With Both Publicly and Privately Insured Adults Doubled. J Am Heart Assoc. 2017 Nov 02; 6(11). PMID: 29097386.
      Citations:    
    28. Booth JN, Li J, Zhang L, Chen L, Muntner P, Egan B. Trends in Prehypertension and Hypertension Risk Factors in US Adults: 1999-2012. Hypertension. 2017 08; 70(2):275-284. PMID: 28607131.
      Citations:    
    29. Sarasua SM, Li J, Hernandez GT, Ferdinand KC, Tobin JN, Fiscella KA, Jones DW, Sinopoli A, Egan BM. Opportunities for improving cardiovascular health outcomes in adults younger than 65 years with guideline-recommended statin therapy. J Clin Hypertens (Greenwich). 2017 Sep; 19(9):850-860. PMID: 28480530.
      Citations:    
    30. Tobin WO, Kinsella JA, Kavanagh GF, O'Donnell JS, McGrath RT, Tierney S, Egan B, Feeley TM, Coughlan T, Collins DR, O'Neill D, Murphy S, Lim SJ, Murphy RP, McCabe D. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes. J Neurol Sci. 2017 Apr 15; 375:404-410. PMID: 28320178.
      Citations:    
    31. Egan BM. Physical Activity and Hypertension: Knowing Is Not Enough; We Must Apply. Willing Is Not Enough; We Must Do-von Goethe. Hypertension. 2017 03; 69(3):404-406. PMID: 28137989.
      Citations:    
    32. Turan TN, Nizam A, Lynn MJ, Egan BM, Le NA, Lopes-Virella MF, Hermayer KL, Harrell J, Derdeyn CP, Fiorella D, Janis LS, Lane B, Montgomery J, Chimowitz MI. Relationship between risk factor control and vascular events in the SAMMPRIS trial. Neurology. 2017 Jan 24; 88(4):379-385. PMID: 28003500.
      Citations:    
    33. Egan BM, Kai B, Wagner CS, Fleming DO, Henderson JH, Chandler AH, Sinopoli A. Low Blood Pressure Is Associated With Greater Risk for Cardiovascular Events in Treated Adults With and Without Apparent Treatment-Resistant Hypertension. J Clin Hypertens (Greenwich). 2017 Mar; 19(3):241-249. PMID: 27767292.
      Citations:    
    34. Egan BM, Li J, White K, Fleming DO, Connell K, Hernandez GT, Jones DW, Ferdinand KC, Sinopoli A. 2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals. J Am Heart Assoc. 2016 08 19; 5(8). PMID: 27543306.
      Citations:    
    35. Lopes HF, Corrêa-Giannella ML, Consolim-Colombo FM, Egan BM. Visceral adiposity syndrome. Diabetol Metab Syndr. 2016; 8:40. PMID: 27437032.
      Citations:    
    36. Egan BM, Li J, Wagner CS. Systolic Blood Pressure Intervention Trial (SPRINT) and Target Systolic Blood Pressure in Future Hypertension Guidelines. Hypertension. 2016 08; 68(2):318-23. PMID: 27354422.
      Citations:    
    37. Egan BM, Laken MA, Sutherland SE, Qanungo S, Fleming DO, Cook AG, Hester WH, Jones KW, Jebaily GC, Valainis GT, Way CF, Wright MB, Davis RA. Aldosterone Antagonists or Renin-Guided Therapy for Treatment-Resistant Hypertension: A Comparative Effectiveness Pilot Study in Primary Care. Am J Hypertens. 2016 08; 29(8):976-83. PMID: 27076600.
      Citations:    
    38. Motta JM, Lemos TM, Consolim-Colombo FM, Moyses RM, Gusmão MA, Egan BM, Lopes HF. Abnormalities of Anthropometric, Hemodynamic, and Autonomic Variables in Offspring of Hypertensive Parents. J Clin Hypertens (Greenwich). 2016 09; 18(9):942-8. PMID: 26935870.
      Citations:    
    39. Egan BM, Kai B, Wagner CS, Henderson JH, Chandler AH, Sinopoli A. Blood Pressure Control Provides Less Cardiovascular Protection in Adults With Than Without Apparent Treatment-Resistant Hypertension. J Clin Hypertens (Greenwich). 2016 08; 18(8):817-24. PMID: 26856795.
      Citations:    
    40. Egan BM, Sutherland SE, Childers WF, Dahlheimer RM, Helmrich GA, Lapeyrolerie DA, Markle N, Murphy DW, Simmons L, Davis RA, Tilkemeier P, Sinopoli A. Comparative impact of implementing the 2013 or 2014 cholesterol guideline on vascular events in a quality improvement network. Ther Adv Cardiovasc Dis. 2016 Apr; 10(2):56-66. PMID: 26733598.
      Citations:    
    41. Egan BM, Li J, Fleming DO, White K, Connell K, Davis RA, Sinopoli A. Impact of Implementing the 2013 ACC/AHA Cholesterol Guidelines on Vascular Events in a Statewide Community-Based Practice Registry. J Clin Hypertens (Greenwich). 2016 07; 18(7):663-71. PMID: 26606899.
      Citations:    
    42. Egan BM. Treatment Resistant Hypertension. Ethn Dis. 2015 Nov 05; 25(4):495-8. PMID: 26674466.
      Citations:    
    43. Puckrein GA, Egan BM, Howard G. Social and Medical Determinants of Cardiometabolic Health: The Big Picture. Ethn Dis. 2015 Nov 05; 25(4):521-4. PMID: 26673674.
      Citations:    
    44. Egan BM, White K. Weight Loss Pharmacotherapy: Brief Summary of the Clinical Literature and Comments on Racial Differences. Ethn Dis. 2015 Nov 05; 25(4):511-4. PMID: 26675365.
      Citations:    
    45. Sperling LS, Mechanick JI, Neeland IJ, Herrick CJ, Després JP, Ndumele CE, Vijayaraghavan K, Handelsman Y, Puckrein GA, Araneta MR, Blum QK, Collins KK, Cook S, Dhurandhar NV, Dixon DL, Egan BM, Ferdinand DP, Herman LM, Hessen SE, Jacobson TA, Pate RR, Ratner RE, Brinton EA, Forker AD, Ritzenthaler LL, Grundy SM. The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome. J Am Coll Cardiol. 2015 Sep 01; 66(9):1050-67. PMID: 26314534.
      Citations:    
    46. Egan BM, Stevens-Fabry S. The importance of masked hypertension in adults with prehypertension. Nat Rev Cardiol. 2015 Aug; 12(8):497. PMID: 26149482.
      Citations:    
    47. Egan BM. Elijah Saunders in Memoriam. J Clin Hypertens (Greenwich). 2015 Jun; 17(6):415-7. PMID: 26094721.
      Citations:    
    48. Wilson DK, Van Horn ML, Siceloff ER, Alia KA, St George SM, Lawman HG, Trumpeter NN, Coulon SM, Griffin SF, Wandersman A, Egan B, Colabianchi N, Forthofer M, Gadson B. The Results of the "Positive Action for Today's Health" (PATH) Trial for Increasing Walking and Physical Activity in Underserved African-American Communities. Ann Behav Med. 2015 Jun; 49(3):398-410. PMID: 25385203.
      Citations:    
    49. Carter BL, Coffey CS, Ardery G, Uribe L, Ecklund D, James P, Egan B, Vander Weg M, Chrischilles E, Vaughn T. Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2015 May; 8(3):235-43. PMID: 25805647.
      Citations:    
    50. Egan BM, Bland VJ, Brown AL, Ferdinand KC, Hernandez GT, Jamerson KA, Johnson WR, Kountz DS, Li J, Osei K, Reed JW, Saunders E. Hypertension in african americans aged 60 to 79 years: statement from the international society of hypertension in blacks. J Clin Hypertens (Greenwich). 2015 Apr; 17(4):252-9. PMID: 25756743.
      Citations:    
    51. Egan BM, Stevens-Fabry S. Prehypertension--prevalence, health risks, and management strategies. Nat Rev Cardiol. 2015 May; 12(5):289-300. PMID: 25687779.
      Citations:    
    52. Moran WP, Zhang J, Gebregziabher M, Brownfield EL, Davis KS, Schreiner AD, Egan BM, Greenberg RS, Kyle TR, Marsden JE, Ball SJ, Mauldin PD. Chaos to complexity: leveling the playing field for measuring value in primary care. J Eval Clin Pract. 2017 Apr; 23(2):430-438. PMID: 25652744.
      Citations:    
    53. Nietert PJ, Shaftman SR, Silver RM, Wolf BJ, Egan BM, Hunt KJ, Smith EA. Raynaud phenomenon and mortality: 20+ years of follow-up of the Charleston Heart Study cohort. Clin Epidemiol. 2015; 7:161-8. PMID: 25678814.
      Citations:    
    54. Lopes HF, Klein RL, Garvey WT, Goodfriend T, Egan BM. Influence of acute hyperlipidemia to adipocyte-derived hormones in lean normotensive and subjects with metabolic syndrome. Diabetol Metab Syndr. 2014; 6(1):132. PMID: 25506401.
      Citations:    
    55. Egan BM. Effectiveness of a tailored behavioral intervention to improve hypertension control. Hypertension. 2015 Feb; 65(2):273-5. PMID: 25403609.
      Citations:    
    56. Egan BM, Li J, Hutchison FN, Ferdinand KC. Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals. Circulation. 2014 Nov 04; 130(19):1692-9. PMID: 25332288.
      Citations:    
    57. Boan AD, Egan BM, Bachman DL, Adams RJ, Feng WW, Jauch EC, Ovbiagele B, Lackland DT. Antihypertensive medication persistence 1-year post-stroke hospitalization. J Clin Hypertens (Greenwich). 2014 Dec; 16(12):869-74. PMID: 25307229.
      Citations:    
    58. Hailpern SM, Egan BM, Lewis KD, Wagner C, Shattat GF, Al Qaoud DI, Shatat IF. Blood Pressure, Heart Rate, and CNS Stimulant Medication Use in Children with and without ADHD: Analysis of NHANES Data. Front Pediatr. 2014; 2:100. PMID: 25285304.
      Citations:    
    59. Nashar K, Egan BM. Relationship between chronic kidney disease and metabolic syndrome: current perspectives. Diabetes Metab Syndr Obes. 2014; 7:421-35. PMID: 25258547.
      Citations:    
    60. Egan BM, Li J, Small J, Nietert PJ, Sinopoli A. The growing gap in hypertension control between insured and uninsured adults: National Health and Nutrition Examination Survey 1988 to 2010. Hypertension. 2014 Nov; 64(5):997-1004. PMID: 25185135.
      Citations:    
    61. Hudson SM, Hiott DB, Cole J, Davis R, Egan BM, Laken MA. Increasing capacity for quality improvement in underresourced primary care settings. Qual Manag Health Care. 2014 Jul-Sep; 23(3):155-62. PMID: 24978164.
      Citations:    
    62. Egan BM. Opportunities for multidisciplinary ASH clinical hypertension specialists in an era of population health and accountable care: ASH leadership message. J Am Soc Hypertens. 2014 Jul; 8(7):451-6. PMID: 25064766.
      Citations:    
    63. Egan BM, Li J, Wolfman TE, Sinopoli A. Diabetes and age-related demographic differences in risk factor control. J Am Soc Hypertens. 2014 Jun; 8(6):394-404. PMID: 24952652.
      Citations:    
    64. Tobin WO, Kinsella JA, Kavanagh GF, O'Donnell JS, McGrath RT, Coughlan T, Collins DR, O'Neill D, Egan B, Tierney S, Feeley TM, Murphy RP, McCabe DJ. Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke. J Neurol. 2014 Jul; 261(7):1405-12. PMID: 24781842.
      Citations:    
    65. Egan BM, Li J. Role of aldosterone blockade in resistant hypertension. Semin Nephrol. 2014 May; 34(3):273-84. PMID: 25016399.
      Citations:    
    66. Egan BM, Li J, Shatat IF, Fuller JM, Sinopoli A. Closing the gap in hypertension control between younger and older adults: National Health and Nutrition Examination Survey (NHANES) 1988 to 2010. Circulation. 2014 May 20; 129(20):2052-61. PMID: 24733570.
      Citations:    
    67. Dart RA, Egan BM. Formation of community-based hypertension practice networks: success, obstacles, and lessons learned. J Clin Hypertens (Greenwich). 2014 Jun; 16(6):393-7. PMID: 24666425.
      Citations:    
    68. Egan BM, Zhao Y, Li J, Brzezinski WA, Todoran TM, Brook RD, Calhoun DA. Response to Comment on optimal treatment for resistant hypertension: the missing data on pulse wave velocity. Hypertension. 2014 Mar; 63(3):e17-8. PMID: 24491391.
      Citations:    
    69. Ostrye J, Hailpern SM, Jones J, Egan B, Chessman K, Shatat IF. The efficacy and safety of intravenous hydralazine for the treatment of hypertension in the hospitalized child. Pediatr Nephrol. 2014 Aug; 29(8):1403-9. PMID: 24554119.
      Citations:    
    70. Julius S, Egan BM, Kaciroti NA, Nesbitt SD, Chen AK. In prehypertension leukocytosis is associated with body mass index but not with blood pressure or incident hypertension. J Hypertens. 2014 Feb; 32(2):251-9. PMID: 24275841.
      Citations:    
    71. Jones JB, Shatat IF, Egan BM, Paulo RC. Decreased heart rate variability is associated with increased transcranial Doppler velocities in children with sickle cell disease. Ethn Dis. 2014; 24(4):451-5. PMID: 25417428.
      Citations:    
    72. Gil JS, Drager LF, Guerra-Riccio GM, Mostarda C, Irigoyen MC, Costa-Hong V, Bortolotto LA, Egan BM, Lopes HF. The impact of metabolic syndrome on metabolic, pro-inflammatory and prothrombotic markers according to the presence of high blood pressure criterion. Clinics (Sao Paulo). 2013 Dec; 68(12):1495-501. PMID: 24473506.
      Citations:    
    73. Egan BM, Laken MA. Pre-hypertension: rationale for pharmacotherapy. Curr Hypertens Rep. 2013 Dec; 15(6):669-75. PMID: 24142744.
      Citations:    
    74. Gage H, Egan B, Williams P, Györei E, Brands B, López-Robles JC, Campoy C, Koletzko B, Decsi T, Raats M. Views of parents in four European countries about the effect of food on the mental performance of primary school children. Eur J Clin Nutr. 2014 Jan; 68(1):32-7. PMID: 24281310.
      Citations:    
    75. Egan BM. Prediction of incident hypertension. Health implications of data mining in the 'Big Data' era. J Hypertens. 2013 Nov; 31(11):2123-4. PMID: 24096252.
      Citations:    
    76. Bhagatwala J, Harris RA, Parikh SJ, Zhu H, Huang Y, Kotak I, Seigler N, Pierce GL, Egan BM, Dong Y. Epithelial sodium channel inhibition by amiloride on blood pressure and cardiovascular disease risk in young prehypertensives. J Clin Hypertens (Greenwich). 2014 Jan; 16(1):47-53. PMID: 24410943.
      Citations:    
    77. Egan BM. Collectrin, an X-linked, angiotensin converting enzyme 2 homolog, causes hypertension in a rat strain through gene-gene and gene-environment interactions: relevance to human hypertension. Circulation. 2013 Oct 15; 128(16):1727-8. PMID: 24048199.
      Citations:    
    78. Egan BM, Zhao Y, Li J, Brzezinski WA, Todoran TM, Brook RD, Calhoun DA. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network. Hypertension. 2013 Oct; 62(4):691-7. PMID: 23918752.
      Citations:    
    79. Becton LJ, Egan BM, Hailpern SM, Shatat IF. Blood pressure reclassification in adolescents based on repeat clinic blood pressure measurements. J Clin Hypertens (Greenwich). 2013 Oct; 15(10):717-22. PMID: 24088279.
      Citations:    
    80. Egan BM, Li J, Qanungo S, Wolfman TE. Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010. Circulation. 2013 Jul 02; 128(1):29-41. PMID: 23817481.
      Citations:    
    81. Kinsella JA, Tobin WO, Tierney S, Feeley TM, Egan B, Collins DR, Coughlan T, O'Neill D, Harbison J, Madhavan P, Moore DJ, O'Neill SM, Colgan MP, Doherty CP, Murphy RP, Saqqur M, Moran N, Hamilton G, McCabe DJ. Increased platelet activation in early symptomatic vs. asymptomatic carotid stenosis and relationship with microembolic status: results from the Platelets and Carotid Stenosis Study. J Thromb Haemost. 2013 Jul; 11(7):1407-16. PMID: 23621656.
      Citations:    
    82. Egan BM. Plasma lipidomic profile signature of hypertension in mexican american families. Hypertension. 2013 Sep; 62(3):453-4. PMID: 23798348.
      Citations:    
    83. Elliott WJ, Egan B, Giles TD, Bakris GL, White WB, Sansone TM. Rationale for establishing a mechanism to increase reimbursement to hypertension specialists. J Clin Hypertens (Greenwich). 2013 Jun; 15(6):397-403. PMID: 23730988.
      Citations:    
    84. Carter BL, Coffey CS, Uribe L, James PA, Egan BM, Ardery G, Chrischilles EA, Ecklund D, Vander Weg M, Vaughn T. Similar blood pressure values across racial and economic groups: baseline data from a group randomized clinical trial. J Clin Hypertens (Greenwich). 2013 Jun; 15(6):404-12. PMID: 23730989.
      Citations:    
    85. Coulon SM, Wilson DK, Egan BM. Associations among environmental supports, physical activity, and blood pressure in African-American adults in the PATH trial. Soc Sci Med. 2013 Jun; 87:108-15. PMID: 23631785.
      Citations:    
    86. Egan B, Grassi G. Sympathetic activation and endothelial dysfunction as therapeutic targets in obesity-related hypertension. J Hypertens. 2013 Feb; 31(2):259-60. PMID: 23303351.
      Citations:    
    87. Laken MA, Dawson R, Engelman O, Lovelace O, Way C, Egan BM. Comparative effectiveness research in the "real" world: lessons learned in a study of treatment-resistant hypertension. J Am Soc Hypertens. 2013 Jan-Feb; 7(1):95-101. PMID: 23321408.
      Citations:    
    88. Egan BM, Zhao Y. Different definitions of prevalent hypertension impact: the clinical epidemiology of hypertension and attainment of Healthy People goals. J Clin Hypertens (Greenwich). 2013 Mar; 15(3):154-61. PMID: 23458586.
      Citations:    
    89. Handler J, Zhao Y, Egan BM. Impact of the number of blood pressure measurements on blood pressure classification in US adults: NHANES 1999-2008. J Clin Hypertens (Greenwich). 2012 Nov; 14(11):751-9. PMID: 23126346.
      Citations:    
    90. Tobin WO, Kinsella JA, Kavanagh GF, O'Donnell JS, McGrath RA, Collins DR, Coughlan T, O'Neill D, Egan B, Tierney S, Feeley TM, Murphy RP, McCabe DJ. Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke. J Neurol. 2013 Feb; 260(2):590-6. PMID: 23064666.
      Citations:    
    91. Geisler BP, Egan BM, Cohen JT, Garner AM, Akehurst RL, Esler MD, Pietzsch JB. Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension. J Am Coll Cardiol. 2012 Oct 02; 60(14):1271-7. PMID: 22981547.
      Citations:    
    92. Egan BM. Achievement of cardiometabolic goals in aware hypertensive patients in Spain: implications for population health. Hypertension. 2012 Oct; 60(4):891-3. PMID: 22949536.
      Citations:    
    93. Turan TN, Lynn MJ, Nizam A, Lane B, Egan BM, Le NA, Lopes-Virella MF, Hermayer KL, Benavente O, White CL, Brown WV, Caskey MF, Steiner MR, Vilardo N, Stufflebean A, Derdeyn CP, Fiorella D, Janis S, Chimowitz MI. Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):e51-60. PMID: 22991350.
      Citations:    
    94. Gage H, Williams P, Von Rosen-Von Hoewel J, Laitinen K, Jakobik V, Martin-Bautista E, Schmid M, Egan B, Morgan J, Decsi T, Campoy C, Koletzko B, Raats M. Influences on infant feeding decisions of first-time mothers in five European countries. Eur J Clin Nutr. 2012 Aug; 66(8):914-9. PMID: 22692025.
      Citations:    
    95. Egan BM, Bandyopadhyay D, Shaftman SR, Wagner CS, Zhao Y, Yu-Isenberg KS. Initial monotherapy and combination therapy and hypertension control the first year. Hypertension. 2012 Jun; 59(6):1124-31. PMID: 22566499.
      Citations:    
    96. Deedwania PC, Zappe DH, Egan BM, Purkayastha D, Samuel R, Sowers JR. Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide? J Clin Hypertens (Greenwich). 2012 Jul; 14(7):415-21. PMID: 22747613.
      Citations:    
    97. Selassie A, Wagner S, Laken ML, Egan BM, Ferguson ML, Ferdinand KC. RESPONSE TO 190678: TO TREAT OR NOT TO TREAT SHOULD NO LONGER BE THE QUESTION. Hypertension. 2012 Apr; 59(4). PMID: 25104871.
      Citations:    
    98. Egan BM, Shaftman SR, Wagner CS, Bandyopadhyay D, Szymanski KA. Demographic differences in the treatment and control of glucose in type 2 diabetic patients: implications for health care practice. Ethn Dis. 2012; 22(1):29-37. PMID: 22774306.
      Citations:    
    99. Selassie A, Wagner CS, Laken ML, Ferguson ML, Ferdinand KC, Egan BM. Progression is accelerated from prehypertension to hypertension in blacks. Hypertension. 2011 Oct; 58(4):579-87. PMID: 21911708.
      Citations:    
    100. Trogdon JG, Allaire BT, Egan BM, Lackland DT, Masters D. Training providers in hypertension guidelines: cost-effectiveness evaluation of a continuing medical education program in South Carolina. Am Heart J. 2011 Oct; 162(4):786-793.e1. PMID: 21982674.
      Citations:    
    101. Egan BM. Renal sympathetic denervation: a novel intervention for resistant hypertension, insulin resistance, and sleep apnea. Hypertension. 2011 Oct; 58(4):542-3. PMID: 21844486.
      Citations:    
    102. Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011 Aug 30; 124(9):1046-58. PMID: 21824920.
      Citations:    
    103. Good DW, Al Chalabi H, Al Chalabi H, Hameed F, Egan B, Tierney S, Feeley TM. Popliteo-pedal bypass surgery for critical limb ischemia. Ir J Med Sci. 2011 Dec; 180(4):829-35. PMID: 21800035.
      Citations:    
    104. Raij L, Egan BM, Zappe DH, Purkayastha D, Samuel R, Sowers JR. Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patients. J Clin Hypertens (Greenwich). 2011 Oct; 13(10):731-8. PMID: 21974760.
      Citations:    
    105. Egan BM, Laken MA, Shaun Wagner C, Mack SS, Seymour-Edwards K, Dodson J, Zhao Y, Lackland DT. Impacting population cardiovascular health through a community-based practice network: update on an ASH-supported collaborative. J Clin Hypertens (Greenwich). 2011 Aug; 13(8):543-50. PMID: 21806763.
      Citations:    
    106. Egan BM, Laken MA. Is blood pressure control to less than 140/less than 90 mmHg in 50% of all hypertensive patients as good as we can do in the USA: or is this as good as it gets? Curr Opin Cardiol. 2011 Jul; 26(4):300-7. PMID: 21597369.
      Citations:    
    107. Allaire BT, Trogdon JG, Egan BM, Lackland DT, Masters D. Measuring the impact of a continuing medical education program on patient blood pressure. J Clin Hypertens (Greenwich). 2011 Jul; 13(7):517-22. PMID: 21762365.
      Citations:    
    108. Baruth M, Wilcox S, Egan BM, Dowda M, Laken M, Warren TY. Cardiovascular disease risk factor clustering among African American adults. Ethn Dis. 2011; 21(2):129-34. PMID: 21749014.
      Citations:    
    109. Andersen K, Weinberger MH, Egan B, Constance CM, Wright M, Lukashevich V, Keefe DL. Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trial. Cardiovasc Ther. 2010 Dec; 28(6):344-9. PMID: 20406241.
      Citations:    
    110. Egan BM. Overnight rostral fluid shift and obstructive sleep apnea in treatment resistant hypertension: connecting the dots clarifies the picture. Hypertension. 2010 Dec; 56(6):1040-1. PMID: 21059995.
      Citations:    
    111. Egan BM, Lackland DT, Jones DW. Prehypertension: an opportunity for a new public health paradigm. Cardiol Clin. 2010 Nov; 28(4):561-9. PMID: 20937441.
      Citations:    
    112. Axon RN, Garrell R, Pfahl K, Fisher JE, Zhao Y, Egan B, Weder A. Attitudes and practices of resident physicians regarding hypertension in the inpatient setting. J Clin Hypertens (Greenwich). 2010 Sep; 12(9):698-705. PMID: 20883230.
      Citations:    
    113. Wilson DK, Trumpeter NN, St George SM, Coulon SM, Griffin S, Lee Van Horn M, Lawman HG, Wandersman A, Egan B, Forthofer M, Goodlett BD, Kitzman-Ulrich H, Gadson B. An overview of the "Positive Action for Today's Health" (PATH) trial for increasing walking in low income, ethnic minority communities. Contemp Clin Trials. 2010 Nov; 31(6):624-33. PMID: 20801233.
      Citations:    
    114. Sowers JR, Raij L, Jialal I, Egan BM, Ofili EO, Samuel R, Zappe DH, Purkayastha D, Deedwania PC. Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives. J Hypertens. 2010 Aug; 28(8):1761-9. PMID: 20498618.
      Citations:    
    115. Axon RN, Cousineau L, Egan BM. Prevalence and management of hypertension in the inpatient setting: a systematic review. J Hosp Med. 2011 Sep; 6(7):417-22. PMID: 20652961.
      Citations:    
    116. Carter BL, Clarke W, Ardery G, Weber CA, James PA, Vander Weg M, Chrischilles EA, Vaughn T, Egan BM. A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2010 Jul; 3(4):418-23. PMID: 20647575.
      Citations:    
    117. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010 May 26; 303(20):2043-50. PMID: 20501926.
      Citations:    
    118. Egan BM, Laken MA, Donovan JL, Woolson RF. Does dark chocolate have a role in the prevention and management of hypertension?: commentary on the evidence. Hypertension. 2010 Jun; 55(6):1289-95. PMID: 20404213.
      Citations:    
    119. Axon RN, Nietert PJ, Egan BM. Antihypertensive medication prescribing patterns in a university teaching hospital. J Clin Hypertens (Greenwich). 2010 Apr; 12(4):246-52. PMID: 20433545.
      Citations:    
    120. Howard VJ, Woolson RF, Egan BM, Nicholas JS, Adams RJ, Howard G, Lackland DT. Prevalence of hypertension by duration and age at exposure to the stroke belt. J Am Soc Hypertens. 2010 Jan-Feb; 4(1):32-41. PMID: 20374949.
      Citations:    
    121. Al-Solaiman Y, Jesri A, Mountford WK, Lackland DT, Zhao Y, Egan BM. DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre. J Hum Hypertens. 2010 Apr; 24(4):237-46. PMID: 19626043.
      Citations:    
    122. Egan BM. Pleiotropic benefits of moderate salt reduction. Hypertension. 2009 Sep; 54(3):447-8. PMID: 19620511.
      Citations:    
    123. Al-Solaiman Y, Jesri A, Zhao Y, Morrow JD, Egan BM. Low-Sodium DASH reduces oxidative stress and improves vascular function in salt-sensitive humans. J Hum Hypertens. 2009 Dec; 23(12):826-35. PMID: 19404315.
      Citations:    
    124. Egan BM, Basile JN, Rehman SU, Davis PB, Grob CH, Riehle JF, Walters CA, Lackland DT, Merali C, Sealey JE, Laragh JH. Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens. 2009 Jul; 22(7):792-801. PMID: 19373213.
      Citations:    
    125. Egan BM. Fixed-dose combinations and hypertension control in community-based practices: application of the "keep-it-simple" principle. Hypertension. 2009 Apr; 53(4):598-9. PMID: 19237677.
      Citations:    
    126. Lackland DT, Egan BM, Mountford WK, Boan AD, Evans DA, Gilbert G, McGee DL. Thirty-year Survival for Black and White Hypertensive Individuals in the Evans County Heart Study and the Hypertension Detection and Follow-up Program. J Am Soc Hypertens. 2008 Nov-Dec; 2(6):448-54. PMID: 19169432.
      Citations:    
    127. Axon RN, Bradford WD, Egan BM. The role of individual time preferences in health behaviors among hypertensive adults: a pilot study. J Am Soc Hypertens. 2009 Jan-Feb; 3(1):35-41. PMID: 20409943.
      Citations:    
    128. Egan BM. Sleep-disordered breathing and blood pressure in children. Hypertension. 2008 Nov; 52(5):807. PMID: 18838622.
      Citations:    
    129. Egan BM, Julius S. Prehypertension: risk stratification and management considerations. Curr Hypertens Rep. 2008 Oct; 10(5):359-66. PMID: 18775112.
      Citations:    
    130. Lackland DT, Egan BM. Sodium intake and mortality: the debate continues. J Gen Intern Med. 2008 Sep; 23(9):1537-8. PMID: 18663539.
      Citations:    
    131. Moser M, Houston M, Svetkey L, Egan B. Dietary management in the prevention and treatment of hypertension: does it work? J Clin Hypertens (Greenwich). 2008 Aug; 10(8):632-9. PMID: 18772646.
      Citations:    
    132. Egan BM, Nesbitt SD, Julius S. Prehypertension: should we be treating with pharmacologic therapy? Ther Adv Cardiovasc Dis. 2008 Aug; 2(4):305-14. PMID: 19124429.
      Citations:    
    133. Williams SA, Michelson EL, Cain VA, Yang M, Nesbitt SD, Egan BM, Julius S. An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY). J Clin Hypertens (Greenwich). 2008 Jun; 10(6):436-42. PMID: 18550933.
      Citations:    
    134. King DE, Mainous AG, Egan BM, Woolson RF, Geesey ME. Effect of psyllium fiber supplementation on C-reactive protein: the trial to reduce inflammatory markers (TRIM). Ann Fam Med. 2008 Mar-Apr; 6(2):100-6. PMID: 18332401.
      Citations:    
    135. Andersen K, Weinberger MH, Egan B, Constance CM, Ali MA, Jin J, Keefe DL. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial. J Hypertens. 2008 Mar; 26(3):589-99. PMID: 18300872.
      Citations:    
    136. Julius S, Kaciroti N, Egan BM, Nesbitt S, Michelson EL. TROPHY study: Outcomes based on the Seventh Report of the Joint National Committee on Hypertension definition of hypertension. J Am Soc Hypertens. 2008 Jan-Feb; 2(1):39-43. PMID: 20409883.
      Citations:    
    137. Abell JE, Egan BM, Wilson PW, Lipsitz S, Woolson RF, Lackland DT. Differences in cardiovascular disease mortality associated with body mass between Black and White persons. Am J Public Health. 2008 Jan; 98(1):63-6. PMID: 18048799.
      Citations:    
    138. Gadegbeku CA, Dhandayuthapani A, Taylor TP, Shrayyef Z, Gerich J, Garvey WT, Egan BM. Insulin's actions on plasma free fatty acids are normal in patients with stage 2 to 3 chronic kidney disease. J Am Soc Hypertens. 2007 Nov-Dec; 1(6):414-22. PMID: 20409874.
      Citations:    
    139. Egan BM. Combination therapy with an angiotensin-converting enzyme inhibitor and a calcium channel blocker. J Clin Hypertens (Greenwich). 2007 Oct; 9(10):783-9. PMID: 17917506.
      Citations:    
    140. King DE, Mainous AG, Egan BM, Player M, Geesey ME. Use of statins and blood pressure. Am J Hypertens. 2007 Sep; 20(9):937-41. PMID: 17765132.
      Citations:    
    141. Lackland DT, Egan BM. Dietary salt restriction and blood pressure in clinical trials. Curr Hypertens Rep. 2007 Aug; 9(4):314-9. PMID: 17686383.
      Citations:    
    142. Abell JE, Egan BM, Wilson PW, Lipsitz S, Woolson RF, Lackland DT. Age and race impact the association between BMI and CVD mortality in women. Public Health Rep. 2007 Jul-Aug; 122(4):507-12. PMID: 17639654.
      Citations:    
    143. King DE, Egan BM, Woolson RF, Mainous AG, Al-Solaiman Y, Jesri A. Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Med. 2007 Mar 12; 167(5):502-6. PMID: 17353499.
      Citations:    
    144. Julius S, Schork A, Egan BM. From TROPHY with pride. Am J Hypertens. 2007 Mar; 20(3):342-3; author reply 343-5. PMID: 17324750.
      Citations:    
    145. Gilliard TS, Lackland DT, Mountford WK, Egan BM. Concordance between self-reported heights and weights and current and ideal body images in young adult African American men and women. Ethn Dis. 2007; 17(4):617-23. PMID: 18072369.
      Citations:    
    146. Egan BM, Lackland DT, Igho-Pemu P, Hendrix KH, Basile J, Rehman SU, Okonofua EC, Quarshie A, Oduwole A, Onwuanyi A, Reed J, Obialo C, Ofili EO. Cardiovascular risk factor control in communities--update from the ASH Carolinas-Georgia Chapter, the Hypertension Initiative, and the Community Physicians' Network. J Clin Hypertens (Greenwich). 2006 Dec; 8(12):879-86. PMID: 17170614.
      Citations:    
    147. Lopes HF, Egan BM. Autonomic dysregulation and the metabolic syndrome: pathologic partners in an emerging global pandemic. Arq Bras Cardiol. 2006 Oct; 87(4):538-47. PMID: 17128327.
      Citations:    
    148. Messerli FH, Bangalore S, Egan BM, Julius S. Does life-long reduction in low-density lipoprotein cholesterol reduce the risk of new-onset hypertension? Am J Cardiol. 2006 Oct 15; 98(8):1122. PMID: 17027588.
      Citations:    
    149. Gadegbeku CA, Shrayyef MZ, Taylor TP, Egan BM. Mechanism of lipid enhancement of alpha1-adrenoceptor pressor sensitivity in hypertension. J Hypertens. 2006 Jul; 24(7):1383-9. PMID: 16794488.
      Citations:    
    150. Egan BM. Sleep and hypertension: burning the candle at both ends really is hazardous to your health. Hypertension. 2006 May; 47(5):816-7. PMID: 16585409.
      Citations:    
    151. King DE, Egan BM, Mainous AG, Geesey ME. The effect of extended-release metoprolol succinate on C-reactive protein levels in persons with hypertension. J Clin Hypertens (Greenwich). 2006 Apr; 8(4):257-60. PMID: 16596028.
      Citations:    
    152. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, Black HR, Grimm RH, Messerli FH, Oparil S, Schork MA. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006 Apr 20; 354(16):1685-97. PMID: 16537662.
      Citations:    
    153. Miller PM, Spies C, Neumann T, Javors MA, Hoyumpa AM, Roache J, Webb A, Kashi M, Sharkey FE, Anton RF, Egan BM, Basile J, Nguyen S, Fleming MF, Dillie KS. Alcohol biomarker screening in medical and surgical settings. Alcohol Clin Exp Res. 2006 Feb; 30(2):185-93. PMID: 16441267.
      Citations:    
    154. Fan Z, Lackland DT, Lipsitz SR, Nicholas JS, Egan BM, Tim Garvey W, Hutchison FN. Geographical patterns of end-stage renal disease incidence and risk factors in rural and urban areas of South Carolina. Health Place. 2007 Mar; 13(1):179-87. PMID: 16443385.
      Citations:    
    155. Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006 Mar; 47(3):345-51. PMID: 16432045.
      Citations:    
    156. Egan BM. Challenges and risks in attaining the systolic blood pressure goal of <130 mm Hg in all diabetic patients. J Clin Hypertens (Greenwich). 2006 Jan; 8(1):50-2. PMID: 16407689.
      Citations:    
    157. Jesri A, Okonofua EC, Egan BM. Platelet and white blood cell counts are elevated in patients with the metabolic syndrome. J Clin Hypertens (Greenwich). 2005 Dec; 7(12):705-11; quiz 712-3. PMID: 16330892.
      Citations:    
    158. Coffee RE, Nicholas JS, Egan BM, Rumboldt Z, D'Agostino S, Patel SJ. Arterial compression of the retro-olivary sulcus of the medulla in essential hypertension: a multivariate analysis. J Hypertens. 2005 Nov; 23(11):2027-31. PMID: 16208145.
      Citations:    
    159. Hendrix KH, Mayhan S, Lackland DT, Egan BM. Prevalence, treatment, and control of chest pain syndromes and associated risk factors in hypertensive patients. Am J Hypertens. 2005 Aug; 18(8):1026-32. PMID: 16109315.
      Citations:    
    160. Riehle JF, Lackland DT, Okonofua EC, Hendrix KH, Egan BM. Ethnic differences in the treatment and control of hypertension in patients with diabetes. J Clin Hypertens (Greenwich). 2005 Aug; 7(8):445-54. PMID: 16103755.
      Citations:    
    161. Hendrix KH, Mayhan S, Egan BM. Gender- and age-related differences in treatment and control of cardiovascular risk factors among high-risk patients with angina. J Clin Hypertens (Greenwich). 2005 Jul; 7(7):386-94. PMID: 16015048.
      Citations:    
    162. Egan BM, Basile J, Chilton RJ, Cohen JD. Cardioprotection: the role of beta-blocker therapy. J Clin Hypertens (Greenwich). 2005 Jul; 7(7):409-16. PMID: 16015051.
      Citations:    
    163. Liszka HA, Mainous AG, King DE, Everett CJ, Egan BM. Prehypertension and cardiovascular morbidity. Ann Fam Med. 2005 Jul-Aug; 3(4):294-9. PMID: 16046560.
      Citations:    
    164. Nesbitt SD, Julius S, Leonard D, Egan BM, Grozinski M. Is low-risk hypertension fact or fiction? cardiovascular risk profile in the TROPHY study. Am J Hypertens. 2005 Jul; 18(7):980-5. PMID: 16053996.
      Citations:    
    165. Okonofua EC, Cutler NE, Lackland DT, Egan BM. Ethnic differences in older americans: awareness, knowledge, and beliefs about hypertension. Am J Hypertens. 2005 Jul; 18(7):972-9. PMID: 16053995.
      Citations:    
    166. Houston MC, Basile J, Bestermann WH, Egan B, Lackland D, Hawkins RG, Moore MA, Reed J, Rogers P, Wise D, Ferrario CM. Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States. Am J Med Sci. 2005 Jun; 329(6):276-91. PMID: 15958870.
      Citations:    
    167. King DE, Mainous AG, Egan BM, Woolson RF, Geesey ME. Fiber and C-reactive protein in diabetes, hypertension, and obesity. Diabetes Care. 2005 Jun; 28(6):1487-9. PMID: 15920074.
      Citations:    
    168. Bestermann W, Houston MC, Basile J, Egan B, Ferrario CM, Lackland D, Hawkins RG, Reed J, Rogers P, Wise D, Moore MA. Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome. Am J Med Sci. 2005 Jun; 329(6):292-305. PMID: 15958871.
      Citations:    
    169. Miller PM, Anton RF, Egan BM, Basile J, Nguyen SA. Excessive alcohol consumption and hypertension: clinical implications of current research. J Clin Hypertens (Greenwich). 2005 Jun; 7(6):346-51. PMID: 16088298.
      Citations:    
    170. Rehman SU, Hutchison FN, Hendrix K, Okonofua EC, Egan BM. Ethnic differences in blood pressure control among men at Veterans Affairs clinics and other health care sites. Arch Intern Med. 2005 May 09; 165(9):1041-7. PMID: 15883244.
      Citations:    
    171. Standridge JB, Sealey JE, Laragh JH, Houston MC, Gavras H, Johnson RJ, Blumenfeld JD, Brown M, Egan BM, Meltzer JI, Shimosawa T, Fujita T. A free-ranging roundtable discussion on hypertension. J Hum Hypertens. 2005 Apr; 19(4):259-66. PMID: 15716983.
      Citations:    
    172. Egan BM, Papademetriou V, Wofford M, Calhoun D, Fernandes J, Riehle JE, Nesbitt S, Michelson E, Julius S. Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure. Am J Hypertens. 2005 Jan; 18(1):3-12. PMID: 15691610.
      Citations:    
    173. Sheats N, Lin Y, Zhao W, Cheek DE, Lackland DT, Egan BM. Prevalence, treatment, and control of hypertension among African Americans and Caucasians at primary care sites for medically under-served patients. Ethn Dis. 2005; 15(1):25-32. PMID: 15720046.
      Citations:    
    174. Hendrix KH, Riehle JE, Egan BM. Ethnic, gender, and age-related differences in treatment and control of dyslipidemia in hypertensive patients. Ethn Dis. 2005; 15(1):11-6. PMID: 15720044.
      Citations:    
    175. Mainous AG, Everett CJ, Liszka H, King DE, Egan BM. Prehypertension and mortality in a nationally representative cohort. Am J Cardiol. 2004 Dec 15; 94(12):1496-500. PMID: 15589003.
      Citations:    
    176. Egan B, Gleim G, Panish J. Use of losartan in diabetic patients in the primary care setting: review of the results in LIFE and RENAAL. Curr Med Res Opin. 2004 Dec; 20(12):1909-17. PMID: 15701209.
      Citations:    
    177. Bestermann WH, Lackland DT, Riehle JE, Egan BM. A systematic approach to managing hypertension and the metabolic syndrome in primary care. South Med J. 2004 Oct; 97(10):932-8. PMID: 15558916.
      Citations:    
    178. King DE, Egan BM, Mainous AG, Geesey ME. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens (Greenwich). 2004 Oct; 6(10):562-8. PMID: 15470285.
      Citations:    
    179. Gadegbeku CA, Shrayyef MZ, LaPorte FB, Egan BM. Lipids enhance alpha1-adrenoceptor pressor sensitivity in patients with chronic kidney disease. Am J Kidney Dis. 2004 Sep; 44(3):446-54. PMID: 15332217.
      Citations:    
    180. Egan BM. Hypertension in the 21st century: the tide is rising; our daze must end. Hypertension. 2004 Oct; 44(4):389. PMID: 15326092.
      Citations:    
    181. Julius S, Nesbitt S, Egan B, Kaciroti N, Schork MA, Grozinski M, Michelson E. Trial of preventing hypertension: design and 2-year progress report. Hypertension. 2004 Aug; 44(2):146-51. PMID: 15238567.
      Citations:    
    182. Nashar K, Nguyen JP, Jesri A, Morrow JD, Egan BM. Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome. Am J Hypertens. 2004 Jun; 17(6):477-82. PMID: 15177518.
      Citations:    
    183. Goodfriend TL, Ball DL, Egan BM, Campbell WB, Nithipatikom K. Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion. Hypertension. 2004 Feb; 43(2):358-63. PMID: 14718355.
      Citations:    
    184. Basile JN, Lackland DT, Basile JM, Riehle JE, Egan BM. A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension. J Clin Hypertens (Greenwich). 2004 Jan; 6(1):18-25. PMID: 14724420.
      Citations:    
    185. Lackland DT, Lin Y, Tilley BC, Egan BM. An assessment of racial differences in clinical practices for hypertension at primary care sites for medically underserved patients. J Clin Hypertens (Greenwich). 2004 Jan; 6(1):26-31; quiz 32-3. PMID: 14724421.
      Citations:    
    186. Egan BM, Chilton RJ. Other important applications for beta-blockers in high-risk patients. Postgrad Med. 2003 Dec; 114(6 Suppl Role):35-48. PMID: 19667668.
      Citations:    
    187. Cohen JD, Egan BM. The role of sympathetic activation in cardiovascular disease. Postgrad Med. 2003 Dec; 114(6 Suppl Role):4-10. PMID: 19667664.
      Citations:    
    188. King DE, Egan BM, Geesey ME. Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol. 2003 Dec 01; 92(11):1335-9. PMID: 14636916.
      Citations:    
    189. Egan BM. Beta-blockers for cardioprotection. A forgotten message? Postgrad Med. 2003 Dec; 114(6 Suppl Role):3. PMID: 19667663.
      Citations:    
    190. Egan BM, Basile JN. Controlling blood pressure in 50% of all hypertensive patients: an achievable goal in the healthy people 2010 report? J Investig Med. 2003 Nov; 51(6):373-85. PMID: 14686641.
      Citations:    
    191. Hendrix KH, Lackland DT, Egan BM. Cardiovascular risk factor control and treatment patterns in primary care. Manag Care Interface. 2003 Nov; 16(11):21-6. PMID: 14650370.
      Citations:    
    192. Egan BM. Reproducibility of BP responses to changes in dietary salt: compelling evidence for universal sodium restriction? Hypertension. 2003 Oct; 42(4):457-8. PMID: 12939238.
      Citations:    
    193. Giese M, Lackland D, Basile J, Egan B. 2003 update on the Hypertension Initiative of South Carolina. Bringing South Carolina from "worst to first" in cardiovascular health. J S C Med Assoc. 2003 Jun; 99(6):157-61. PMID: 12886701.
      Citations:    
    194. Egan BM. Insulin resistance and the sympathetic nervous system. Curr Hypertens Rep. 2003 Jun; 5(3):247-54. PMID: 12724058.
      Citations:    
    195. Lopes HF, Morrow JD, Stojiljkovic MP, Goodfriend TL, Egan BM, Stoijiljkovic MP. Acute hyperlipidemia increases oxidative stress more in African Americans than in white Americans. Am J Hypertens. 2003 May; 16(5 Pt 1):331-6. PMID: 12745192.
      Citations:    
    196. Egan BM, Lackland DT, Cutler NE. Awareness, knowledge, and attitudes of older americans about high blood pressure: implications for health care policy, education, and research. Arch Intern Med. 2003 Mar 24; 163(6):681-7. PMID: 12639200.
      Citations:    
    197. Lackland DT, Egan BM, Ferguson PL. Low birth weight as a risk factor for hypertension. J Clin Hypertens (Greenwich). 2003 Mar-Apr; 5(2):133-6. PMID: 12671326.
      Citations:    
    198. Lopes HF, Martin KL, Nashar K, Morrow JD, Goodfriend TL, Egan BM. DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension. 2003 Mar; 41(3):422-30. PMID: 12623938.
      Citations:    
    199. Gadegbeku CA, Dhandayuthapani A, Shrayyef MZ, Egan BM. Hemodynamic effects of nicotinic acid infusion in normotensive and hypertensive subjects. Am J Hypertens. 2003 Jan; 16(1):67-71. PMID: 12517686.
      Citations:    
    200. Bakris G, Calhoun D, Egan B, Hellmann C, Dolker M, Kingma I. Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension. J Hypertens. 2002 Nov; 20(11):2257-67. PMID: 12409965.
      Citations:    
    201. Egan BM. Ethnicity and unprovoked hypokalemia in the ARIC Study. Am J Hypertens. 2002 Jul; 15(7 Pt 1):660-1. PMID: 12118918.
      Citations:    
    202. Gadegbeku CA, Dhandayuthapani A, Sadler ZE, Egan BM. Raising lipids acutely reduces baroreflex sensitivity. Am J Hypertens. 2002 Jun; 15(6):479-85. PMID: 12074347.
      Citations:    
    203. Stojiljkovic MP, Lopes HF, Zhang D, Morrow JD, Goodfriend TL, Egan BM. Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster. J Hypertens. 2002 Jun; 20(6):1215-21. PMID: 12023694.
      Citations:    
    204. Lopes HF, Stojiljkovic MP, Zhang D, Goodfriend TL, Egan BM. Moderate sodium restriction enhances the pressor response to hyperlipidemia in obese, hypertensive patients. J Clin Hypertens (Greenwich). 2002 May-Jun; 4(3):173-80. PMID: 12045366.
      Citations:    
    205. Egan BM, Lackland DT, Basile JN. American Society of Hypertension regional chapters: leveraging the impact of the clinical hypertension specialist in the local community. Am J Hypertens. 2002 Apr; 15(4 Pt 1):372-9. PMID: 11991226.
      Citations:    
    206. Lackland DT, Egan BM, Syddall HE, Barker DJ. Associations between birth weight and antihypertensive medication in black and white medicaid recipients. Hypertension. 2002 Jan; 39(1):179-83. PMID: 11799099.
      Citations:    
    207. Foster KY, Diehl NS, Shaw D, Rogers RL, Egan B, Carek P, Tomsic J. Medical students' readiness to provide lifestyle counseling for overweight patients. Eat Behav. 2002; 3(1):1-13. PMID: 15001017.
      Citations:    
    208. Lopes HF, Stojiljkovic MP, Zhang D, Goodfriend TL, Egan BM. The pressor response to acute hyperlipidemia is enhanced in lean normotensive offspring of hypertensive parents. Am J Hypertens. 2001 Oct; 14(10):1032-7. PMID: 11710782.
      Citations:    
    209. Haastrup A, Gadegbeku CA, Zhang D, Mukhin YV, Greene EL, Jaffa AA, Egan BM. Lipids stimulate the production of 6-keto-prostaglandin f(1alpha) in human dorsal hand veins. Hypertension. 2001 Oct; 38(4):858-63. PMID: 11641299.
      Citations:    
    210. Egan BM, Lackland DT, Williams B, Gunter N, Tocharoen A, Beardon L. Health care improvement and cost reduction opportunities in hypertensive Medicaid beneficiaries. J Clin Hypertens (Greenwich). 2001 Sep-Oct; 3(5):279-82, 318. PMID: 11588405.
      Citations:    
    211. Egan BM, Greene EL, Goodfriend TL. Insulin resistance and cardiovascular disease. Am J Hypertens. 2001 Jun; 14(6 Pt 2):116S-125S. PMID: 11411746.
      Citations:    
    212. Stojiljkovic MP, Zhang D, Lopes HF, Lee CG, Goodfriend TL, Egan BM. Hemodynamic effects of lipids in humans. . 2001 Jun; 280(6):R1674-9. PMID: 11353670.
      Citations:    
    213. Egan BM, Greene EL, Goodfriend TL. Nonesterified fatty acids in blood pressure control and cardiovascular complications. Curr Hypertens Rep. 2001 Apr; 3(2):107-16. PMID: 11276390.
      Citations:    
    214. Giese M, Lackland DT, Egan BM. The hypertension initiative of South Carolina. Promoting cardiovascular health through better blood pressure control. J S C Med Assoc. 2001 Feb; 97(2):57-62. PMID: 11235117.
      Citations:    
    215. Egan BM, Chen G, Kelly CJ, Bouchier-Hayes DJ. Taurine attenuates LPS-induced rolling and adhesion in rat microcirculation. J Surg Res. 2001 Feb; 95(2):85-91. PMID: 11162030.
      Citations:    
    216. Greene EL, Lu G, Zhang D, Egan BM. Signaling events mediating the additive effects of oleic acid and angiotensin II on vascular smooth muscle cell migration. Hypertension. 2001 Feb; 37(2):308-12. PMID: 11230290.
      Citations:    
    217. Lackland DT, Egan BM, Fan ZJ, Syddall HE. Low birth weight contributes to the excess prevalence of end-stage renal disease in African Americans. J Clin Hypertens (Greenwich). 2001 Jan-Feb; 3(1):29-31. PMID: 11416679.
      Citations:    
    218. Oexmann MJ, Ascanio R, Egan BM. Efficacy of a church-based intervention on cardiovascular risk reduction. Ethn Dis. 2001; 11(4):817-22. PMID: 11763306.
      Citations:    
    219. Egan BM, Lackland DT. Biochemical and metabolic effects of very-low-salt diets. Am J Med Sci. 2000 Oct; 320(4):233-9. PMID: 11061347.
      Citations:    
    220. Gajjar D, Egan B, Curè J, Rust P, VanTassel P, Patel SJ. Vascular compression of the rostral ventrolateral medulla in sympathetic mediated essential hypertension. Hypertension. 2000 Jul; 36(1):78-82. PMID: 10904016.
      Citations:    
    221. Lackland DT, Bendall HE, Osmond C, Egan BM, Barker DJ. Low birth weights contribute to high rates of early-onset chronic renal failure in the Southeastern United States. Arch Intern Med. 2000 May 22; 160(10):1472-6. PMID: 10826460.
      Citations:    
    222. Oexmann MJ, Thomas JC, Taylor KB, O'Neil PM, Garvey WT, Lackland DT, Egan BM. Short-term impact of a church-based approach to lifestyle change on cardiovascular risk in African Americans. Ethn Dis. 2000; 10(1):17-23. PMID: 10764126.
      Citations:    
    223. Lackland DT, Egan BM. The dominant role of systolic hypertension as a vascular risk factor: evidence from the southeastern United States. Am J Med Sci. 1999 Dec; 318(6):365-8. PMID: 10616160.
      Citations:    
    224. Jones D, Basile J, Cushman W, Egan B, Ferrario C, Hill M, Lackland D, Mensah G, Moore M, Ofili E, Roccella EJ, Smith R, Taylor H. Managing hypertension in the southeastern United States: applying the guidelines from the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Am J Med Sci. 1999 Dec; 318(6):357-64. PMID: 10616159.
      Citations:    
    225. Lackland DT, Egan BM, Jones PJ. Impact of nativity and race on "Stroke Belt" mortality. Hypertension. 1999 Jul; 34(1):57-62. PMID: 10406824.
      Citations:    
    226. Egan BM, Lu G, Greene EL. Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster. Prostaglandins Leukot Essent Fatty Acids. 1999 May-Jun; 60(5-6):411-20. PMID: 10471131.
      Citations:    
    227. Goodfriend TL, Egan BM, Kelley DE. Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans. Prostaglandins Leukot Essent Fatty Acids. 1999 May-Jun; 60(5-6):401-5. PMID: 10471129.
      Citations:    
    228. Mahon NG, Codd MB, O'Rorke C, Egan B, McCann HA, Sugrue DD. Management and outcome of acute myocardial infarction in older patients in the thrombolytic era. J Am Geriatr Soc. 1999 Mar; 47(3):291-4. PMID: 10078890.
      Citations:    
    229. Lu G, Greene EL, Nagai T, Egan BM. Reactive oxygen species are critical in the oleic acid-mediated mitogenic signaling pathway in vascular smooth muscle cells. Hypertension. 1998 Dec; 32(6):1003-10. PMID: 9856964.
      Citations:    
    230. Haastrup AT, Stepniakowski KT, Goodfriend TL, Egan BM. Intralipid enhances alpha1-adrenergic receptor mediated pressor sensitivity. Hypertension. 1998 Oct; 32(4):693-8. PMID: 9774365.
      Citations:    
    231. Lane KB, Egan B, Vick S, Abdolrasulnia R, Shepherd VL. Characterization of a rat alveolar macrophage cell line that expresses a functional mannose receptor. J Leukoc Biol. 1998 Sep; 64(3):345-50. PMID: 9738661.
      Citations:    
    232. Goodfriend TL, Egan BM, Kelley DE. Aldosterone in obesity. Endocr Res. 1998 Aug-Nov; 24(3-4):789-96. PMID: 9888579.
      Citations:    
    233. Barone BM, Egan BM, Brown TE, Resch ML, Woodard LJ, Trogdon KP, Lackland DT. Commun-I-Care: experience in the first four years. J S C Med Assoc. 1998 Jul; 94(7):318-22. PMID: 9689784.
      Citations:    
    234. Lu G, Meier KE, Jaffa AA, Rosenzweig SA, Egan BM. Oleic acid and angiotensin II induce a synergistic mitogenic response in vascular smooth muscle cells. Hypertension. 1998 Apr; 31(4):978-85. PMID: 9535424.
      Citations:    
    235. Egan BM, Lackland DT. Strategies for cardiovascular disease prevention: importance of public and community health programs. Ethn Dis. 1998; 8(2):228-39. PMID: 9681288.
      Citations:    
    236. Stepniakowski KT, Lu G, Davda RK, Egan BM. Fatty acids augment endothelium-dependent dilation in hand veins by a cyclooxygenase-dependent mechanism. Hypertension. 1997 Dec; 30(6):1634-9. PMID: 9403594.
      Citations:    
    237. Stepniakowski KT, Lu G, Miller GD, Egan BM. Fatty acids, not insulin, modulate alpha1-adrenergic reactivity in dorsal hand veins. Hypertension. 1997 Nov; 30(5):1150-5. PMID: 9369269.
      Citations:    
    238. Goodfriend TL, Egan BM. Nonesterified fatty acids in the pathogenesis of hypertension: theory and evidence. Prostaglandins Leukot Essent Fatty Acids. 1997 Jul; 57(1):57-63. PMID: 9250609.
      Citations:    
    239. Hall WD, Ferrario CM, Moore MA, Hall JE, Flack JM, Cooper W, Simmons JD, Egan BM, Lackland DT, Perry M, Roccella EJ. Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci. 1997 Apr; 313(4):195-209. PMID: 9099149.
      Citations:    
    240. Eck LH, Bennett AG, Egan BM, Ray JW, Mitchell CO, Smith MA, Klesges RC. Differences in macronutrient selections in users and nonusers of an oral contraceptive. Am J Clin Nutr. 1997 Feb; 65(2):419-24. PMID: 9022525.
      Citations:    
    241. Egan BM, Stepniakowski KT. Adverse effects of short-term, very-low-salt diets in subjects with risk-factor clustering. Am J Clin Nutr. 1997 02; 65(2 Suppl):671S-677S. PMID: 9022563.
      Citations:    
    242. McCarron DA, Weder AB, Egan BM, Krishna GG, Morris CD, Cohen M, Oparil S. Blood pressure and metabolic responses to moderate sodium restriction in isradipine-treated hypertensive patients. Am J Hypertens. 1997 Jan; 10(1):68-76. PMID: 9008250.
      Citations:    
    243. Lu G, Morinelli TA, Meier KE, Rosenzweig SA, Egan BM. Oleic acid-induced mitogenic signaling in vascular smooth muscle cells. A role for protein kinase C. Circ Res. 1996 Sep; 79(3):611-8. PMID: 8781494.
      Citations:    
    244. Alexander CN, Schneider RH, Staggers F, Sheppard W, Clayborne BM, Rainforth M, Salerno J, Kondwani K, Smith S, Walton KG, Egan B. Trial of stress reduction for hypertension in older African Americans. II. Sex and risk subgroup analysis. Hypertension. 1996 Aug; 28(2):228-37. PMID: 8707387.
      Citations:    
    245. Hennes MM, O'Shaughnessy IM, Kelly TM, LaBelle P, Egan BM, Kissebah AH. Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system. Hypertension. 1996 Jul; 28(1):120-6. PMID: 8675251.
      Citations:    
    246. Stepniakowski KT, Sallee FR, Goodfriend TL, Zhang Z, Egan BM. Fatty acids enhance neurovascular reflex responses by effects on alpha 1-adrenoceptors. Am J Physiol. 1996 Jun; 270(6 Pt 2):R1340-6. PMID: 8764302.
      Citations:    
    247. Ullian ME, Hazen-Martin DJ, Walsh LG, Davda RK, Egan BM. Carbenoxolone damages endothelium and enhances vasoconstrictor action in aortic rings. Hypertension. 1996 Jun; 27(6):1346-52. PMID: 8641747.
      Citations:    
    248. Small EJ, Srinivas S, Egan B, McMillan A, Rearden TP. Doxorubicin and dose-escalated cyclophosphamide with granulocyte colony-stimulating factor for the treatment of hormone-resistant prostate cancer. J Clin Oncol. 1996 May; 14(5):1617-25. PMID: 8622080.
      Citations:    
    249. Egan BM, Hennes MM, Stepniakowski KT, O'Shaughnessy IM, Kissebah AH, Goodfriend TL. Obesity hypertension is related more to insulin's fatty acid than glucose action. Hypertension. 1996 Mar; 27(3 Pt 2):723-8. PMID: 8613231.
      Citations:    
    250. Egan B, O'Byrne JM, O'Farrell D, O'Donnell A, Wood AE, Neligan MC, O'Brien TM. Orthopaedic complications following cardiac transplantation. Ir Med J. 1996 Jan-Feb; 89(1):26-7. PMID: 8984077.
      Citations:    
    251. Davda RK, Stepniakowski KT, Lu G, Ullian ME, Goodfriend TL, Egan BM. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension. 1995 Nov; 26(5):764-70. PMID: 7591016.
      Citations:    
    252. O'Shaughnessy IM, Myers TJ, Stepniakowski K, Nazzaro P, Kelly TM, Hoffmann RG, Egan BM, Kissebah AH. Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension. 1995 Jul; 26(1):186-92. PMID: 7607722.
      Citations:    
    253. Kjeldsen SE, Weder AB, Egan B, Neubig R, Zweifler AJ, Julius S. Effect of circulating epinephrine on platelet function and hematocrit. Hypertension. 1995 May; 25(5):1096-105. PMID: 7737722.
      Citations:    
    254. Stepniakowski KT, Goodfriend TL, Egan BM. Fatty acids enhance vascular alpha-adrenergic sensitivity. Hypertension. 1995 Apr; 25(4 Pt 2):774-8. PMID: 7721431.
      Citations:    
    255. Stepniakowski K, Egan BM. Additive effects of obesity and hypertension to limit venous volume. Am J Physiol. 1995 Feb; 268(2 Pt 2):R562-8. PMID: 7864253.
      Citations:    
    256. Goodfriend TL, Egan B, Stepniakowski K, Ball DL. Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans. Hypertension. 1995 Jan; 25(1):30-6. PMID: 7843750.
      Citations:    
    257. Kenny D, Egan BM. Is there a role for dietary fish oil in the treatment of hypertension? J Hum Hypertens. 1994 Dec; 8(12):895-905. PMID: 7884788.
      Citations:    
    258. Egan BM, Stepniakowski K, Goodfriend TL. Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering. Am J Hypertens. 1994 Oct; 7(10 Pt 1):886-93. PMID: 7826551.
      Citations:    
    259. Egan BM, Stepniakowski K. Compensatory hyperinsulinemia and the forearm vasodilator response during an oral glucose-tolerance test in obese hypertensives. J Hypertens. 1994 Sep; 12(9):1061-7. PMID: 7852750.
      Citations:    
    260. Nazzaro P, Stepniakowski K, O'Shaughnessy IM, Kissebah AH, Egan BM. Elevated blood pressures in obese young men with mild hypertension are sustained during the day and night. Am J Hypertens. 1994 Jul; 7(7 Pt 1):609-14. PMID: 7946162.
      Citations:    
    261. Egan BM, Stepniakowski K, Zweifler AJ. Ketanserin's sympatholytic and serotonin2-receptor blocking actions precede the hypotensive effects. J Hum Hypertens. 1994 Jan; 8(1):59-64. PMID: 8151608.
      Citations:    
    262. Egan BM, Stepniakowski K, Nazzaro P. Insulin levels are similar in obese salt-sensitive and salt-resistant hypertensive subjects. Hypertension. 1994 Jan; 23(1 Suppl):I1-7. PMID: 8282338.
      Citations:    
    263. Neahring JM, Stepniakowski K, Greene AS, Egan BM. Insulin does not reduce forearm alpha-vasoreactivity in obese hypertensive or lean normotensive men. Hypertension. 1993 Oct; 22(4):584-90. PMID: 8406664.
      Citations:    
    264. Egan BM, Fleissner MJ, Stepniakowski K, Neahring JM, Sagar KB, Ebert TJ. Improved baroreflex sensitivity in elderly hypertensives on lisinopril is not explained by blood pressure reduction alone. J Hypertens. 1993 Oct; 11(10):1113-20. PMID: 8258676.
      Citations:    
    265. Egan BM, Stepniakowski K. Effects of enalapril on the hyperinsulinemic response to severe salt restriction in obese young men with mild systemic hypertension. Am J Cardiol. 1993 Jul 01; 72(1):53-7. PMID: 8517428.
      Citations:    
    266. Shin HH, Sagar KB, Stepniakowski K, Wetherbee JN, Egan BM. Increased prevalence of abnormal signal-averaged electrocardiograms in older patients who have hypertension with low diastolic blood pressure. Am Heart J. 1993 Jun; 125(6):1698-703. PMID: 8498313.
      Citations:    
    267. Kenny D, Warltier DC, Pleuss JA, Hoffmann RG, Goodfriend TL, Egan BM. Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men. Am J Cardiol. 1992 Nov 15; 70(15):1347-52. PMID: 1442589.
      Citations:    
    268. Egan BM. Hypertension, diuretics, and coronary heart disease: a case of apples and oranges, reciprocal prejudice, and a partially-clad emperor? Am J Hypertens. 1992 Sep; 5(9):665-6. PMID: 1418856.
      Citations:    
    269. Egan BM. Adaptive changes in cerebral blood vessels during chronic hypertension. J Hypertens. 1992 Apr; 10(4):399-400. PMID: 1316407.
      Citations:    
    270. Egan B. Cardiovascular risk factors, clustering and complications in overweight young men. Med Sect Proc. 1992; 107-15. PMID: 1306546.
      Citations:    
    271. Egan BM, Petrin J, Hoffmann RG. NaCl induces differential changes of regional vascular reactivity in salt-sensitive versus salt-resistant men. Am J Hypertens. 1991 Dec; 4(12 Pt 1):924-31. PMID: 1815648.
      Citations:    
    272. Egan BM. Neurohumoral, hemodynamic and microvascular changes as mechanisms of insulin resistance in hypertension: a provocative but partial picture. Int J Obes. 1991 Sep; 15 Suppl 2:133-9. PMID: 1686606.
      Citations:    
    273. Goodfriend TL, Ball DL, Weinberger MH, Moore TJ, Weder AB, Egan BM. Salt loads raise plasma fatty acids and lower insulin. Hypertension. 1991 Jun; 17(6 Pt 2):958-64. PMID: 2045176.
      Citations:    
    274. Egan BM, Weder AB, Petrin J, Hoffman RG. Neurohumoral and metabolic effects of short-term dietary NaCl restriction in men. Relationship to salt-sensitivity status. Am J Hypertens. 1991 May; 4(5 Pt 1):416-21. PMID: 1676891.
      Citations:    
    275. Egan BM, Bassett DR, Block WD. Comparative effects of overweight on cardiovascular risk in younger versus older men. Am J Cardiol. 1991 Feb 01; 67(4):248-52. PMID: 1990787.
      Citations:    
    276. Weder AB, Egan BM. Potential deleterious impact of dietary salt restriction on cardiovascular risk factors. Klin Wochenschr. 1991; 69 Suppl 25:45-50. PMID: 1921252.
      Citations:    
    277. Sekkarie MA, Egan BM, Neubig RR, Supiano MA. Sensitization of human alpha 1- and alpha 2-adrenergic venous responses by guanadrel sulfate. Clin Pharmacol Ther. 1990 Nov; 48(5):537-43. PMID: 2171846.
      Citations:    
    278. Mejia AD, Egan BM, Schork NJ, Zweifler AJ. Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension. Ann Intern Med. 1990 Feb 15; 112(4):270-7. PMID: 2297205.
      Citations:    
    279. Egan BM. Neurogenic mechanisms initiating essential hypertension. Am J Hypertens. 1989 Dec; 2(12 Pt 2):357S-362S. PMID: 2688692.
      Citations:    
    280. Petrin J, Egan BM, Julius S. Increased beta-adrenergic tone enhances arterial compliance in hyperkinetic borderline hypertension. J Hypertens Suppl. 1989 Dec; 7(6):S78-9. PMID: 2561152.
      Citations:    
    281. Egan B, Fitzpatrick MA, Juni J, Buda AJ, Zweifler A. Importance of overweight in studies of left ventricular hypertrophy and diastolic function in mild systemic hypertension. Am J Cardiol. 1989 Oct 01; 64(12):752-5. PMID: 2529753.
      Citations:    
    282. Egan BM, Schork NJ, Weder AB. Regional hemodynamic abnormalities in overweight men. Focus on alpha-adrenergic vascular responses. Am J Hypertens. 1989 Jun; 2(6 Pt 1):428-34. PMID: 2547397.
      Citations:    
    283. Dananberg J, Egan BM, Bates ER, Grekin RJ. Sustained saline-induced secretion of atrial natriuretic hormone is not maintained by atrial stretch. J Clin Endocrinol Metab. 1989 Apr; 68(4):735-9. PMID: 2522101.
      Citations:    
    284. Weder AB, Egan BM. Erythrocyte water, Na+-K+ cotransport, and forearm vascular function in humans. Hypertension. 1988 Aug; 12(2):199-203. PMID: 3410528.
      Citations:    
    285. Egan B, Schmouder R. The importance of hemodynamic considerations in essential hypertension. Am Heart J. 1988 Aug; 116(2 Pt 2):594-9. PMID: 3293403.
      Citations:    
    286. Egan B, Conlon ME, Campbell R, Schork N, Zwiefler A, Julius S. Effects of ketanserin on blood pressure and platelet aggregation in elderly men with mild hypertension. Am J Hypertens. 1988 Jul; 1(3 Pt 3):324S-330S. PMID: 3415805.
      Citations:    
    287. Egan B, Schork N, Panis R, Hinderliter A. Vascular structure enhances regional resistance responses in mild essential hypertension. J Hypertens. 1988 Jan; 6(1):41-8. PMID: 3351293.
      Citations:    
    288. Egan B, Panis R, Hinderliter A, Schork N, Julius S. Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest. 1987 Sep; 80(3):812-7. PMID: 3040806.
      Citations:    
    289. Weder AB, Fitzpatrick MA, Torretti BA, Hinderliter AL, Egan BM, Julius S. Red blood cell Li+-Na+ countertransport, Na+-K+ cotransport, and the hemodynamics of hypertension. Hypertension. 1987 May; 9(5):459-66. PMID: 3570422.
      Citations:    
    290. Egan B, Fitzpatrick MA, Julius S. The heart and the regulation of renin. Circulation. 1987 Jan; 75(1 Pt 2):I130-3. PMID: 3539401.
      Citations:    
    291. Fitzpatrick MA, Hinderliter AL, Egan BM, Julius S. Decreased venous distensibility and reduced renin responsiveness in hypertension. Hypertension. 1986 Jun; 8(6 Pt 2):II36-43. PMID: 3522419.
      Citations:    
    292. Schneider RH, Egan BM, Johnson EH, Drobny H, Julius S. Anger and anxiety in borderline hypertension. Psychosom Med. 1986 Mar-Apr; 48(3-4):242-8. PMID: 3704087.
      Citations:    
    293. Egan B. Management of the patient with borderline hypertension. J Cardiovasc Pharmacol. 1986; 8 Suppl 5:S103-7. PMID: 2427865.
      Citations:    
    294. Egan B, Neubig R, Julius S. Pharmacologic reduction of sympathetic drive increases platelet alpha-2-receptor number. Clin Pharmacol Ther. 1985 Nov; 38(5):519-24. PMID: 2996819.
      Citations:    
    295. Egan B. Nutritional and lifestyle approaches to the prevention and management of hypertension. Compr Ther. 1985 Aug; 11(8):15-20. PMID: 4042584.
      Citations:    
    296. Egan B, Neubig R, Schneider RH, Julius S. Methods for measuring vascular and nonvascular alpha-receptor sensitivity in humans. J Cardiovasc Pharmacol. 1985; 7 Suppl 6:S153-8. PMID: 2414579.
      Citations:    
    297. Egan B, Julius S. Vascular hypertrophy in borderline hypertension: relationship to blood pressure and sympathetic drive. Clin Exp Hypertens A. 1985; 7(2-3):243-55. PMID: 4006239.
      Citations:    
    298. Egan B, Grekin R, Ibsen H, Osterziel K, Julius S. Role of cardiopulmonary mechanoreceptors in ADH release in normal humans. Hypertension. 1984 Nov-Dec; 6(6 Pt 1):832-6. PMID: 6440862.
      Citations:    
    299. Egan BM, Julius S, Cottier C, Osterziel KJ, Ibsen H. Role of cardiovascular receptors on the neural regulation of renin release in normal men. Hypertension. 1983 Sep-Oct; 5(5):779-86. PMID: 6352484.
      Citations:    
    300. Julius S, Cottier C, Egan B, Ibsen H, Kiowski W. Cardiopulmonary mechanoreceptors and renin release in humans. Fed Proc. 1983 Jul; 42(10):2703-8. PMID: 6345203.
      Citations:    
    301. Egan B, Julius S. Borderline hypertension. Prim Care. 1983 Mar; 10(1):99-113. PMID: 6348822.
      Citations:    
    302. Ibsen H, Egan B, Osterziel K, Vander A, Julius S. Reflex-hemodynamic adjustments and baroreflex sensitivity during converting enzyme inhibition with MK-421 in normal humans. Hypertension. 1983 Mar-Apr; 5(2 Pt 2):I184-91. PMID: 6298103.
      Citations:    
    303. Egan B, Waxweiler RJ, Blade L, Wolfe J, Wagoner JK. A preliminary report of mortality patterns among foundry workers. J Environ Pathol Toxicol. 1979 May-Jun; 2(5):259-72. PMID: 512558.
      Citations:    
    304. McNicholl B, Egan B. Congenital pernicious anemia: effects on growth, brain, and absorption of B12. Pediatrics. 1968 Jul; 42(1):149-56. PMID: 5657671.
      Citations:    
    Egan's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (775)
    Explore
    _
    Co-Authors (67)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _